Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability

References

• Aksoylu Özbek Z, Günç Ergönül P. (2020). Optimisation of wall material composition of freeze-dried pumpkin seed oil microcapsules: interaction effects of whey protein, maltodextrin, and gum arabic by D-optimal mixture design approach. Food Hydrocoll 107:105909.
   Web of Science ®Google Scholar
• Allison SD, Molina MdC, Anchordoquy TJ. (2000). Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta Biomembr 1468:127–38.
   PubMed Web of Science ®Google Scholar
• Amis TM, Renukuntla J, Bolla PK, Clark BA. (2020). Selection of cryoprotectant in lyophilization of progesterone-loaded stearic acid solid lipid nanoparticles. Pharmaceutics 12:892.
   PubMed Web of Science ®Google Scholar
• Buckton G, Beezer AE. (1992). The relationship between particle size and solubility. Int J Pharm 82:R7–R10.
   Web of Science ®Google Scholar
• Bulcão RP, Freitas FA, Venturini CG, et al. (2013). Acute and subchronic toxicity evaluation of poly(ε-caprolactone) lipid-core nanocapsules in rats. Toxicol Sci 132:162–76.
   PubMed Web of Science ®Google Scholar
• Carneiro AF, Carneiro CN, de N Pires L, et al. (2020). D-optimal mixture design for the optimization of extraction induced by emulsion breaking for multielemental determination in edible vegetable oils by microwave-induced plasma optical emission spectrometry. Talanta 219:121218.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang Y, Zhang J, et al. (2014). Bexarotene nanocrystal—oral and parenteral formulation development, characterization and pharmacokinetic evaluation. Eur J Pharm Biopharm 87:160–9.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wu W, Lu Y. (2020). What is the future for nanocrystal-based drug-delivery systems? Ther Deliv 11:225–9.
   PubMed Web of Science ®Google Scholar
• Dandekar P, Dhumal R, Jain R, et al. (2010). Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies. Food Chem Toxicol 48:2073–89.
   PubMed Web of Science ®Google Scholar
• de la Harpe KM, Kondiah PPD, Choonara YE, et al. (2019). The hemocompatibility of nanoparticles: a review of cell–nanoparticle interactions and hemostasis. Cells 8:1209.
   PubMed Web of Science ®Google Scholar
• De Waard H, Hinrichs WLJ, Frijlink HW. (2008). A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. J Control Release 128:179–83.
   PubMed Web of Science ®Google Scholar
• Din Fu, Kim DW, Choi JY, et al. (2017). Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration. Acta Biomater 54:239–48.
   PubMed Web of Science ®Google Scholar
• Fontana F, Figueiredo P, Zhang P, et al. (2018). Production of pure drug nanocrystals and nano co-crystals by confinement methods. Adv Drug Deliv Rev 131:3–21.
   PubMed Web of Science ®Google Scholar
• Giannini EG, Testa R, Savarino V. (2005). Liver enzyme alteration: a guide for clinicians. CMAJ 172:367–79.
   PubMed Web of Science ®Google Scholar
• Gide P, Sonawane S, Chitnis A. (2012). Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma. J Pharm Anal 2:390–3.
   PubMedGoogle Scholar
• Gigliobianco MR, Casadidio C, Censi R, Di Martino P. (2018). Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability. Pharmaceutics 10:134.
   PubMed Web of Science ®Google Scholar
• Gol D, Thakkar S, Misra M. (2018). Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization. Drug Dev Ind Pharm 44:1458–66.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 17:397–404.
   PubMed Web of Science ®Google Scholar
• Hashim Ali K, Mohsin Ansari M, Ali Shah F, et al. (2019). Enhanced dissolution of valsartan–vanillin binary co-amorphous system loaded in mesoporous silica particles. J Microencapsul 36:10–20.
   PubMed Web of Science ®Google Scholar
• Jaipal A, Pandey MM, Charde SY, et al. (2015). Effect of HPMC and mannitol on drug release and bioadhesion behavior of buccal discs of buspirone hydrochloride: in-vitro and in-vivo pharmacokinetic studies. Saudi Pharm J 23:315–26.
   PubMed Web of Science ®Google Scholar
• Jeirani Z, Mohamed Jan B, Si Ali B, et al. (2012). The optimal mixture design of experiments: alternative method in optimizing the aqueous phase composition of a microemulsion. Chemometr Intell Lab Syst 112:1–7.
   Web of Science ®Google Scholar
• Junyaprasert VB, Morakul B. (2015). Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci 10:13–23.
   Web of Science ®Google Scholar
• Kaialy W, Khan U, Mawlud S. (2016). Influence of mannitol concentration on the physicochemical, mechanical and pharmaceutical properties of lyophilised mannitol. Int J Pharm 510:73–85.
   PubMedGoogle Scholar
• Kakran M, Shegokar R, Sahoo NG, et al. (2012). Fabrication of quercetin nanocrystals: comparison of different methods. Eur J Pharm Biopharm 80:113–21.
   PubMed Web of Science ®Google Scholar
• Keck CM, Müller RH. (2006). Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 62:3–16.
   PubMed Web of Science ®Google Scholar
• Kendre PN, Chaudhari PD. (2017). Effect of polyvinyl caprolactam–polyvinyl acetate–polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets. Drug Dev Ind Pharm 43:751–61.
   PubMed Web of Science ®Google Scholar
• Khames A. (2019). Formulation and characterization of eplerenone nanoemulsion liquisolids, an oral delivery system with higher release rate and improved bioavailability. Pharmaceutics 11:40.
   PubMed Web of Science ®Google Scholar
• Khan N, Shah FA, Rana I, et al. (2020). Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity. Int J Pharm 577:119033.
   PubMed Web of Science ®Google Scholar
• Kim JS, Park JH, Jeong SC, et al. (2018). Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailability. J Microencapsul 35:421–7.
   PubMed Web of Science ®Google Scholar
• Kim JS, ud Din F, Lee SM, et al. (2021). Comparative study between high-pressure homogenisation and Shirasu porous glass membrane technique in sildenafil base-loaded solid SNEDDS: effects on physicochemical properties and in vivo characteristics. Int J Pharm 592:120039.
   PubMedGoogle Scholar
• Kipp JE. (2004). The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 284:109–22.
   PubMed Web of Science ®Google Scholar
• Koradia KD, Parikh RH, Koradia HD. (2018). Albendazole nanocrystals: optimization, spectroscopic, thermal and anthelmintic studies. J Drug Deliv Sci Technol 43:369–78.
   Web of Science ®Google Scholar
• Kumar KN, Mallik S, Sarkar K. (2017). Role of freeze-drying in the presence of mannitol on the echogenicity of echogenic liposomes. J Acoust Soc Am 142:3670.
   PubMed Web of Science ®Google Scholar
• Kurakula M, El-Helw AM, Sobahi TR, Abdelaal MY. (2015). Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy. Int J Nanomedicine 10:321–34.
   PubMed Web of Science ®Google Scholar
• Lee MK, Kim MY, Kim S, Lee J. (2009). Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate. J Pharm Sci 98:4808–17.
   PubMed Web of Science ®Google Scholar
• Liu T, Yu X, Yin H, Möschwitzer JP. (2019). Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery. Drug Deliv 26:1092–103.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li Y, Wu W. (2016). Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B 6:106–13.
   PubMed Web of Science ®Google Scholar
• Mohammady M, Mohammadi Y, Yousefi G. (2020). Freeze-drying of pharmaceutical and nutraceutical nanoparticles: the effects of formulation and technique parameters on nanoparticles characteristics. J Pharm Sci 109:3235–47.
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Stone V, Donaldson K. (2007). Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1:2–25.
   Web of Science ®Google Scholar
• Özdemir S, Çelik B, Sümer E, et al. (2018). Eplerenone nanoemulsions for treatment of hypertension. Part II: physical stability assessment and in vivo study. J Drug Deliv Sci Technol 45:287–95.
   Web of Science ®Google Scholar
• Ozdemir S, Çelik B, Türköz Acar E, et al. (2018). Eplerenone nanoemulsions for treatment of hypertension. Part I: experimental design for optimization of formulations and physical characterization. J Drug Deliv Sci Technol 45:357–66.
   Web of Science ®Google Scholar
• Peltonen L, Hirvonen J. (2018). Drug nanocrystals – versatile option for formulation of poorly soluble materials. Int J Pharm 537:73–83.
   PubMedGoogle Scholar
• Plöger GF, Hofsäss MA, Dressman JB. (2018). Solubility determination of active pharmaceutical ingredients which have been recently added to the list of essential medicines in the context of the Biopharmaceutics Classification System-biowaiver. J Pharm Sci 107:1478–88.
   PubMed Web of Science ®Google Scholar
• Radfar R, Hosseini H, Farhoodi M, et al. (2020). Optimization of antibacterial and mechanical properties of an active LDPE/starch/nanoclay nanocomposite film incorporated with date palm seed extract using D-optimal mixture design approach. Int J Biol Macromol 158:790–9.
   Web of Science ®Google Scholar
• Radwan SE-S, Sokar MS, Abdelmonsif DA, El-Kamel AH. (2017). Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: in vitro and in vivo evaluation/sub-acute toxicity study. Int J Pharm 526:366–79.
   PubMed Web of Science ®Google Scholar
• Rana I, Khan N, Ansari MM, et al. (2020). Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. Colloids Surf B Biointerfaces 194:111209.
   PubMed Web of Science ®Google Scholar
• Rizvi SZH, Shah FA, Khan N, et al. (2019). Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model. Int J Pharm 560:136–43.
   PubMed Web of Science ®Google Scholar
• Rubab S, Naeem K, Rana I, et al. (2021). Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int J Pharm 603:120670.
   PubMed Web of Science ®Google Scholar
• Saleem U, Ahmad B, Ahmad M, et al. (2016). Is folklore use of Euphorbia helioscopia devoid of toxic effects? Drug Chem Toxicol 39:233–7.
   PubMed Web of Science ®Google Scholar
• Sameti M, Bohr G, Ravi Kumar MN, et al. (2003). Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int J Pharm 266:51–60.
   PubMed Web of Science ®Google Scholar
• Sanoj Rejinold N, Muthunarayanan M, Divyarani VV, et al. (2011). Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J Colloid Interface Sci 360:39–51.
   PubMed Web of Science ®Google Scholar
• Sarwar HS, Sohail MF, Saljoughian N, et al. (2018). Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis. Artif Cells Nanomed Biotechnol 46:521–31.
   PubMed Web of Science ®Google Scholar
• Schroeter A, Engelbrecht T, Neubert RHH, Goebel ASB. (2010). New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol 6:511–28.
   PubMed Web of Science ®Google Scholar
• Seferovic PM, Pelliccia F, Zivkovic I, et al. (2015). Mineralocorticoid receptor antagonists, a class beyond spironolactone—focus on the special pharmacologic properties of eplerenone. Int J Cardiol 200:3–7.
   PubMed Web of Science ®Google Scholar
• Sellers RS, Morton D, Michael B, et al. (2007). Society of toxicologic pathology position paper: organ weight recommendations for toxicology studies. Toxicol Pathol 35:751–5.
   PubMed Web of Science ®Google Scholar
• Shegokar R, Müller RH. (2010). Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 399:129–39.
   PubMed Web of Science ®Google Scholar
• Shete G, Pawar YB, Thanki K, et al. (2015). Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology. Mol Pharm 12:1158–70.
   PubMed Web of Science ®Google Scholar
• Sohail MF, Hussain SZ, Saeed H, et al. (2018). Polymeric nanocapsules embedded with ultra-small silver nanoclusters for synergistic pharmacology and improved oral delivery of docetaxel. Sci Rep 8:13304.
   PubMed Web of Science ®Google Scholar
• Thakkar S, Sharma D, Misra M. (2018). Comparative evaluation of electrospraying and lyophilization techniques on solid state properties of erlotinib nanocrystals: assessment of in-vitro cytotoxicity. Eur J Pharm Sci 111:257–69.
   PubMed Web of Science ®Google Scholar
• Tian Z, Mai Y, Meng T, et al. (2021). Nanocrystals for improving oral bioavailability of drugs: intestinal transport mechanisms and influencing factors. AAPS PharmSciTech 22:179.
   PubMed Web of Science ®Google Scholar
• Van Drooge DJ, Hinrichs WLJ, Frijlink HW. (2004). Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent. J Pharm Sci 93:713–25.
   PubMed Web of Science ®Google Scholar
• Visetvichaporn V, Kim K-H, Jung K, et al. (2020). Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235). Int J Pharm 573:118772.
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Charman SA, et al. (2013). Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65:315–499.
   PubMed Web of Science ®Google Scholar
• Wu M, Feng Z, Deng Y, et al. (2019). Liquid antisolvent precipitation: an effective method for ocular targeting of lutein esters. Int J Nanomedicine 14:2667–81.
   PubMed Web of Science ®Google Scholar
• Yu G, Ali Z, Sajjad Khan A, et al. (2021a). Preparation, pharmacokinetics, and antitumor potential of miltefosine-loaded nanostructured lipid carriers. Int J Nanomedicine 16:3255–73.
   PubMed Web of Science ®Google Scholar
• Yu H, Kim JS, Kim DW, et al. (2021b). Novel composite double-layered dressing with improved mechanical properties and wound recovery for thermosensitive drug, Lactobacillus brevis. Compos B Eng 225:109276.
   Web of Science ®Google Scholar
• Zeb A, Qureshi OS, Kim HS, et al. (2017a). High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration. J Pharm Pharmacol 69:955–66.
   PubMed Web of Science ®Google Scholar
• Zeb A, Qureshi OS, Yu C-H, et al. (2017b). Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Int J Pharm 525:92–100.
   PubMed Web of Science ®Google Scholar
• Zhang J, Lv H, Jiang K, Gao Y. (2011). Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm 420:180–8.
   PubMed Web of Science ®Google Scholar